UBQLN4 and cancer: Data integration showed that in patients with LIHC, BRCA, LUAD, UCEC, SKCM, and CESC cancer types, UBQLN4 gene amplification positively correlated with enhanced UBQLN4 mRNA levels and is a prognostic factor for OS in all stages (Figure 2E).